Levocetirizine Teva

Levocetirizine Dihydrochloride, the active ingredient in Levocetirizine Teva, is an antihistamine presented as an oral tablet for systemic use. It treats allergic rhinitis and chronic idiopathic urticaria in adults and adolescents.

GNH USA supplies Levocetirizine Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocetirizine Teva is used to manage allergic conditions mediated by histamine H1 receptors.

Allergic rhinitis: reduces nasal congestion, sneezing, and itching associated with seasonal or perennial allergies. Chronic idiopathic urticaria: alleviates persistent hives and itching in patients with unexplained chronic urticaria. Allergic conjunctivitis: provides relief of eye itching and redness caused by histamine release.

Levocetirizine may cause adverse reactions, which are generally mild but can be serious in rare cases.

Common Side Effects: - Headache: mild to moderate headache. - Dry mouth: sensation of oral dryness. - Drowsiness: mild sedation, especially at treatment start. - Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring emergency care. - Stevens‑Johnson syndrome: rare severe skin reaction. - Thrombocytopenia: significant drop in platelet count. - Hepatic dysfunction: elevated liver enzymes indicating liver stress.

Before initiating therapy, consider the following precautions. - Pregnancy: safety not established; use only if clearly needed. - Breastfeeding: assess risk versus benefit before use. - Renal impairment: dose adjustment may be required; monitor renal function. - Elderly: increased sensitivity to sedative effects; start with lowest effective dose. - Concomitant CNS depressants: may enhance drowsiness; monitor patient. - Store at ambient temperature: keep below 25 °C, protect from moisture and light in original packaging.

Levocetirizine can interact with other medicines; review patient medication lists.

Major Interactions (Avoid): - Alcohol: may potentiate drowsiness and impair cognition. - Strong CYP3A4 inhibitors (e.g., ketoconazole): can increase levocetirizine plasma levels. - Monoamine oxidase inhibitors: risk of additive antihistaminic effects.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): may increase sedation. - Other antihistamines: additive antihistaminic effect, risk of excessive sedation. - Ritonavir: may modestly raise levocetirizine concentrations.